Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient
Medication-induced cutaneous hyperpigmentation has variable clinical presentations and is dependent on the specific drug involved. Most commonly, an attentive patient observes such changes early in the course; when missed by the patient, such changes are usually noted by an observant clinician. Clin...
Saved in:
Main Authors: | Shakuntala S. Patil, Sachin M. Patil, Ryan Campbell, Manisha Singh, Matthew Plotkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/6186471 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
by: Ryan Jalleh, et al.
Published: (2018-01-01) -
Hyperpigmentation heralding relapse of active dermatomyositis in an indian patient
by: Mahathi Kunduru, et al.
Published: (2022-01-01) -
Levofloxacin-induced visual hallucinations: A case report and review of the literature
by: Valentina Raffaelli, et al.
Published: (2018-03-01) -
Capecitabine-induced Hand-foot Syndrome with Hyperpigmentation on Oral Mucosa and Nails: A Rare Entity
by: Suprit Malali, et al.
Published: (2025-02-01) -
Successful Use of Octreotide Therapy for Refractory Levofloxacin-Induced Hypoglycemia: A Case Report and Literature Review
by: Matthew R. Watson, et al.
Published: (2019-01-01)